This just came to our attention. John Mahoney, M.D., chief consultant for strategic health innovations at Pitney Bowes writes in a July 2008 supplement to Journal of Managed Care Pharmacy that value-based benefit design really does work when it comes to drug benefits. We’re still skeptical of the whole value-based wall of jargon. But when Pitney Bowes talks about healthcare we listen. Mahoney writes:
“Despite significant skepticism surrounding value-based benefit design, there is growing evidence that these plans can be used in conjunction with careful pharmacy management. In fact, value-based design provides a different lever on pharmacy management and allows for the appropriate drug to be channeled to the appropriate person. Studies demonstrating the adverse impact of high coinsurance levels further augment the argument for value-based benefit design. Value-based benefit design was employed at Pitney Bowes, a $6.1 billion global provider of integrated mailstream solutions, with noticeable success. Patients were either placed in a disease management program or in a secondary program promoting preventive care. The company selectively cut copays to achieve that end, and this total value approach translated into significant savings.”
Subscribe in RSS Reader
[...] buzzword for others it has been around a while. I remember back in the early 2000s when stories of Pitney Bowes kept popping up and then working with a few of our clients (like Marriott) when I was at Express [...]